Patients’ perspective on aspirin during pregnancy: a survey

Jeske M. bij de Weg; Carolien N.H. Abheiden; Marjon A. de Boer; Conni de Groot; Johanna I.P. de Vries

doi:https://doi.org/10.1080/10641955.2020.1777299

Patients’ perspective on aspirin during pregnancy: a survey

Jeske M. bij de Weg, Carolien N.H. Abheiden, Marjon A. de Boer, Conni de Groot, Johanna I.P. de Vries

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

Objective: To elucidate patients’ knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). Methods: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. Results: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). Conclusion: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.

Original language	English
Pages (from-to)	371-378
Number of pages	8
Journal	Hypertension in pregnancy
Volume	39
Issue number	4
DOIs	https://doi.org/10.1080/10641955.2020.1777299
Publication status	Published - Nov 2020

Keywords

Aspirin
HELLP
gestational hypertension
placenta
preeclampsia

Access to Document

https://doi.org/10.1080/10641955.2020.1777299

Cite this

@article{7596a87656004747b7f2793586200595,

title = "Patients{\textquoteright} perspective on aspirin during pregnancy: a survey",

abstract = "Objective: To elucidate patients{\textquoteright} knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). Methods: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. Results: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). Conclusion: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.",

keywords = "Aspirin, HELLP, gestational hypertension, placenta, preeclampsia",

author = "{bij de Weg}, {Jeske M.} and Abheiden, {Carolien N.H.} and {de Boer}, {Marjon A.} and {de Groot}, Conni and {de Vries}, {Johanna I.P.}",

year = "2020",

month = nov,

doi = "https://doi.org/10.1080/10641955.2020.1777299",

language = "English",

volume = "39",

pages = "371--378",

journal = "Hypertension in pregnancy",

issn = "1064-1955",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Patients’ perspective on aspirin during pregnancy

T2 - a survey

AU - bij de Weg, Jeske M.

AU - Abheiden, Carolien N.H.

AU - de Boer, Marjon A.

AU - de Groot, Conni

AU - de Vries, Johanna I.P.

PY - 2020/11

Y1 - 2020/11

N2 - Objective: To elucidate patients’ knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). Methods: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. Results: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). Conclusion: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.

AB - Objective: To elucidate patients’ knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP). Methods: A quantitative survey was performed including women who are members of the patient orgasnization Dutch HELLP Foundation due to a history of HDP. Results: Awareness of the risk-reducing effect of aspirin on HDP was present in 51.9% of the 189 women. The majority was informed by their gynecologist (89.8%) and preferred to be informed by a gynecologist (79.4%), at the postpartum checkup (42.3%) or in the consecutive pregnancy (30.7%), both orally and written (62.4%). Conclusion: Half of the women with a history of HDP were aware of the risk-reducing effect of aspirin in a consecutive pregnancy.

KW - Aspirin

KW - HELLP

KW - gestational hypertension

KW - placenta

KW - preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=85087150909&partnerID=8YFLogxK

U2 - https://doi.org/10.1080/10641955.2020.1777299

DO - https://doi.org/10.1080/10641955.2020.1777299

M3 - Article

C2 - 32564638

SN - 1064-1955

VL - 39

SP - 371

EP - 378

JO - Hypertension in pregnancy

JF - Hypertension in pregnancy

IS - 4

ER -

Patients’ perspective on aspirin during pregnancy: a survey

Abstract

Keywords

Access to Document

Other files and links

Cite this